In order to detect a vulnerable atherosclerotic plaque that is more likely to cause cardiovascular events, one should focus on studying biomarkers more associated with destabilization rather than ...

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

As the current technology stands, clinical use of CT for cellular and molecular imaging of atherosclerosis may be restricted to the narrow use of identifying plaque mineral composition and cellular ...

Table 1. List of clinical studies determining atherosclerotic plaque or gut microbiota composition in individuals with atherosclerosis and other associated cardiovascular diseases vs. healthy controls ...

In conclusion, TNFα therapy holds great promise in reducing CVD and benefitting cardiovascular patients by decreasing atherosclerotic plaque size as well as decreasing several pro-inflammatory ... In ...

Department of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 3, Zürich CH8093, Switzerland ...

COVID-19 isn't just a respiratory illness — it can silently attack the heart. New research reveals that the virus accelerates ...

We investigated the association of serum Ca, P, and CPP to carotid artery atherosclerotic plaque assessed by high-resolution MR vessel wall imaging in acute ischemic stroke patients. Methods: A total ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...